Lamban, Baby Boy .

HRN: 27-78-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/17/2025
09/24/2025
IV
42mg
Q24H
Potentially Septic Newborn
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines